0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover0.00%IV92.31%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
ESSA Pharma Stock Discussion
PR Newswire·
Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC
Across all cohorts of patients including those recently enrolled into cohort four, 81% of patients achieved PSA90, 69% of patients achieved PSA90 in less than 90 days, and 56% of pa...
$ESSA Pharma (EPIX.US)$ saw its stock rise by 22.60% during the previous trading session. This surge in price was accompanied by a notable increase in option volume, which totaled 3.40K. The option market for ESSA Pharma is currently displaying a high l...
No comment yet